Survival of patients with metastatic leiomyosarcoma: the MD Anderson Clinical Center for targeted therapy experience

Advanced stage leiomyosarcoma (LMS) is incurable with current systemic antitumor therapies. Therefore, there is clinical interest in exploring novel therapeutic regimens to treat LMS. We reviewed the medical records of 75 consecutive patients with histologically confirmed metastatic LMS, who had bee...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Cancer Med
Κύριοι συγγραφείς: Wang, Zhijie, Shi, Naiyi, Naing, Aung, Janku, Filip, Subbiah, Vivek, Araujo, Dejka M., Patel, Shreyaskumar R., Ludwig, Joseph A., Ramondetta, Lois M., Levenback, Charles F., Ramirez, Pedro T., Piha‐Paul, Sarina A., Hong, David, Karp, Daniel D., Tsimberidou, Apostolia M., Meric‐Bernstam, Funda, Fu, Siqing
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: John Wiley and Sons Inc. 2016
Θέματα:
Clinical Cancer Research
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5224847/
https://ncbi.nlm.nih.gov/pubmed/27882721
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.956
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια